Vaziri-Gohar Ali A - OmicsDI

Browse
Submit Data
Databases
API

2 Results

Show all Save search Copy query

Show results for

Metabolomics (2)

Repository

MetaboLights (2)

Technology Type

Mass spectrometry (2)

Instrument Platform

Gas Chromatography MS - positive (1)
Liquid Chromatography MS - (1)

Publication Date

2022 (2)

CHEBI ID

CHEBI:30769 (2)
CHEBI:31460 (1)
CHEBI:167877 (1)
CHEBI:177035 (1)
CHEBI:131529 (1)
CHEBI:50603 (1)
CHEBI:31725 (1)
CHEBI:48945 (1)
CHEBI:27036 (1)
CHEBI:33033 (1)
CHEBI:86564 (1)
CHEBI:24040 (1)
CHEBI:28862 (1)
CHEBI:46905 (1)
CHEBI:86537 (1)
CHEBI:74168 (1)
CHEBI:18205 (1)
CHEBI:68566 (1)
CHEBI:15811 (1)
CHEBI:497734 (1)
CHEBI:16497 (1)
CHEBI:18077 (1)
CHEBI:16043 (1)
CHEBI:24548 (1)
CHEBI:25627 (1)
CHEBI:42111 (1)
CHEBI:16039 (1)
CHEBI:125405 (1)
CHEBI:67270 (1)
CHEBI:95115 (1)

Metabolite Name

Uridine 5-triphosphate (1)
Uridine 5-diphosphoglucose (1)
Uridine 5-diphosphate (1)
Trans-trans Muconic acid (1)
S-5-Adenosyl-L-homocysteine (1)
S-2-Aminoethyl-L-cysteine (1)
Remove (1)
O-Phospho-L-Serine (1)
O-Hydroxy hippuric acid (1)
N-Formyl-L-Tyrosine (1)
N-acetylaspartylglutamate (1)
N-Acetyl D-galactosamine (1)
Mevalonic acid 5-phosphate (1)
L-Hydroxyglutaric acid (1)
L-Gluthathione (oxidized) (1)
Inosine 5-triphosphate (1)
Inosine 5-monophosphate (1)
Inosine 5-diphosphate (1)
Guanosine 5-triphosphate (1)
Guanosine 5-diphosphate (1)
Guanosine 3,5-cyclic monophosphate (1)
Glutathone red (1)
GlcNAc (1)
D-Ribulose 1,5-biphosphate (1)
D-Fructose 1,6-biphosphate (1)
Deoxythymidine 5-triphosphate (1)
Deoxyguanosine 5-triphosphate (1)
Deoxycytidine 5-triphosphate (1)
Deoxyadenosine 5-triphosphate (1)
D-+-Galactosamine (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

10

Increased glucose availability sensitizes pancreatic cancer to chemotherapy

Pancreatic cancer (Pancreatic Ductal Adenocarcinoma; PDAC) is highly resistant to chemotherapy. Effective alternative therapies have yet to emerge, and therefore, chemotherapy remains the best available systematic treatment. The discovery of safe and available adjuncts that can improve chemotherapeu...

2022-10-18 | MTBLS6000 | MetaboLights

Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors

Nutrient-deprived conditions in the tumor microenvironment (TME) restrain cancer cell viability due to increased free radicals and reduced energy production. In pancreatic cancer cells, a cytosolic metabolic enzyme, wild-type isocitrate dehydrogenase 1 (wtIDH1), enables the adaptation to these co...

2022-04-29 | MTBLS4722 | MetaboLights

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

10

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data